Skip to search formSkip to main contentSkip to account menu

latanoprost

Known as: Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate, latanoprost [Chemical/Ingredient], Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate 
A prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect. Latanoprost increases uveoscleral… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
PURPOSE To establish a mouse model for the pharmacological analysis of antiglaucoma drugs, considering the effect of variations… 
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To evaluate the 5-year safety and efficacy of adjunctive 0.005% latanoprost once daily. METHODS Patients with primary… 
Highly Cited
1999
Highly Cited
1999
PurposeTo compare intraocular pressure (IOP) after adding either latanoprost or pilocarpine to timolol treatment or switching to… 
Highly Cited
1999
Highly Cited
1999
Purpose To determine the effect of once-daily 0.005% latanoprost on intraocular pressure (IOP) and pulsatile ocular blood flow… 
Highly Cited
1994
Highly Cited
1994
A randomised observer masked clinical study was conducted to assess the additive effect of latanoprost (13,14-dihydro-17-phenyl…